Skip to main content

Guidelines on Radioisotope Treatment of Lymphomas

  • Chapter
  • First Online:
Book cover Clinical Applications of Nuclear Medicine Targeted Therapy

Abstract

The present chapter has the aim to provide the current position of radioimmunotherapy for the treatment of lymphoma, in the main national and international clinical guidelines. In Table 33.1, a summary of clinical indications is reported.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Australian Cancer Network Diagnosis and Management of Lymphoma Guidelines Working Party. Guidelines for the diagnosis and management of lymphoma. The Cancer Council Australia and Australian Cancer Network, Sydney. 2005.

    Google Scholar 

  2. Tennvall J, Fischer M, Delaloye AB, Bombardieri E, Bodei L, Giammarile F, Lassmann M, Oyen W, Brans B, Therapy Committee EANM, Oncology Committee EANM, Dosimetry Committee EANM. EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomabtiuxetan (Zevalin®). Eur J Nucl Med Mol Imaging. 2007;34(4):616–22.

    Article  PubMed  Google Scholar 

  3. London cancer north and east. London cancer guidelines for the management of lymphoma. June 2014; available from the link: https://londoncancer.org.

  4. Dreyling M, Geisler C, Hermine O, Kluin-Nelemans HC, LeGouill S, Rule S, Shpilberg O, Walewski J, Ladetto M, on behalf of the ESMO Guidelines Working Group. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(3):83–92.

    Article  Google Scholar 

  5. Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, Walewski J, André M, Johnson PW, Pfreundschuh M, Ladetto M, on behalf of the ESMO Guidelines Committee. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(5):116–25.

    Article  Google Scholar 

  6. Dreyling M, Ghielmini M, Rule S, Salles G, Vitolo U, Ladetto M, on behalf of the ESMO Guidelines Committee. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(5):63–90.

    Google Scholar 

  7. Balzarotti M, Carbone A, Castagna L, Pinotti G, Ricardi U, Spina M, Tedeschi L, AIOM Linee Guida Linfomi. 2016; available from the link: http://www.aiom.it/professionisti/documenti-scientifici/linee-guida/1,413,1,#TopList.

  8. NCCN guidelines version 3.2017; available from the link: http://www.nccn.org.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mariapaola Cucinotta .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cucinotta, M., Evangelista, L. (2018). Guidelines on Radioisotope Treatment of Lymphomas. In: Bombardieri, E., Seregni, E., Evangelista, L., Chiesa, C., Chiti, A. (eds) Clinical Applications of Nuclear Medicine Targeted Therapy . Springer, Cham. https://doi.org/10.1007/978-3-319-63067-0_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63067-0_33

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63066-3

  • Online ISBN: 978-3-319-63067-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics